1. Mereiter S, Balmaña M, Campos D, Gomes J, Reis CA

Glycosylation in the Era of Cancer-Targeted Therapy: Where Are We Heading? Cancer cell 36: 6-16, 2019.  [Review] 

 doi: 10.1016/j.ccell.2019.06.006 PMID: 31287993.

 

2. Freitas D, Balmaña M, Poças J, Campos D, Osório H, Konstantinidi A, Vakhrushev SY, Magalhães A, Reis CA

Different isolation approaches lead to diverse glycosylated extracellular vesicle populations. Journal of extracellular vesicles 8: 1621131, 2019.  [Article] 

 doi: 10.1080/20013078.2019.1621131 PMID: 31236201.

 

3. Gomes C, Almeida A, Barreira A, Calheiros J, Pinto F, Abrantes R, Costa A, Polonia A, Campos D, Osório H, Sousa H, Pinto-de-Sousa J, Kolarich D, Reis CA

Carcinoembryonic antigen carrying SLeX as a new biomarker of more aggressive gastric carcinomas. Theranostics 9: 7431-7446, 2019.  [Article] 

 doi: 10.7150/thno.33858 PMID: 31695778.

 

4. Freitas D, Campos D, Gomes J, Pinto F, Macedo JA, Matos R, Mereiter S, Pinto MT, Polónia A, Gartner F, Magalhães A, Reis CA

O-glycans truncation modulates gastric cancer cell signaling and transcription leading to a more aggressive phenotype. EBioMedicine 40: 349-362, 2019.  [Article] 

 doi: 10.1016/j.ebiom.2019.01.017 PMID: 30662000.

 

5. Campos D, Freitas D, Gomes J, Magalhães A, Steentoft C, Gomes C, Vester-Christensen MB, Ferreira JA, Afonso LP, Santos LL, Pinto de Sousa J, Mandel U, Clausen H, Vakhrushev SY, Reis CA

Probing the o-glycoproteome of gastric cancer cell lines for biomarker discovery. Molecular & cellular proteomics : MCP 14: 1616-29, 2015.  [Article] 

 doi: 10.1074/mcp.M114.046862 PMID: 25813380.

 

6. Marcos-Silva L, Narimatsu Y, Halim A, Campos D, Yang Z, Tarp MA, Pereira PJ, Mandel U, Bennett EP, Vakhrushev SY, Levery SB, David L, Clausen H

Characterization of binding epitopes of CA125 monoclonal antibodies. Journal of proteome research 13: 3349-59, 2014.  [Article] 

 doi: 10.1021/pr500215g PMID: 24850311.

 

7. Steentoft C, Fuhrmann M, Battisti F, Van Coillie J, Madsen TD, Campos D, Halim A, Vakhrushev SY, Joshi HJ, Schreiber H, Mandel U, Narimatsu Y

A strategy for generating cancer-specific monoclonal antibodies to aberrant O-glycoproteins: identification of a novel dysadherin-Tn antibody. Glycobiology 29: 307-319, 2019.  [Article] 

 doi: 10.1093/glycob/cwz004 PMID: 30726901.

 

8. Reis CA, Campos D, Osório H, Santos LL

Glycopeptide microarray for autoantibody detection in cancer. Expert review of proteomics 8: 435-7, 2011.  [Review] 

 doi: 10.1586/epr.11.30 PMID: 21819298.

 

9. Gipson IK, Mandel U, Menon B, Michaud S, Tisdale A, Campos D, Clausen H

Generation and characterization of a monoclonal antibody to the cytoplasmic tail of MUC16. Glycobiology 27: 920-926, 2017.  [Article] 

 doi: 10.1093/glycob/cwx054 PMID: 28673046.

 

10. Campos D, Freitas D, Gomes J, Reis CA

Glycoengineered cell models for the characterization of cancer O-glycoproteome: an innovative strategy for biomarker discovery. Expert review of proteomics 12: 337-42, 2015.  [Review] 

 doi: 10.1586/14789450.2015.1059758 PMID: 26098314.